Faculdade

Eventos

CATARINA BRITO | 9th Conference Cycle UCIBIO & LAQV

Qua, 06 fevereiro 2019, 12:00 - 13:00
Tipo de evento: 
Seminário
Localização específica: 
Room 217D - Edifício Departamental

CATARINA BRITO
iBET, ITQB-NOVA

 

3D culture approaches to model cellular microenvironment in disease

 

Host: Angelina Palma

9th Conference Cycle UCIBIO & LAQV

 

Abstract

The cellular microenvironment influences cell behavior and modulates many physiological functions and pathological processes. There is increasing awareness that the different cellular players of a specific tissue as well as the heterogeneous molecular components that constitute the extracellular space (e.g., ECM, soluble factors, microvesicles) influence disease progression and therapeutic response. The major challenge in studying the underlying mechanisms is the lack of human cell models in which the different contributing cell types are represented and the dynamics of the cellular and extracellular spaces recapitulated without the confounding effects of heterologous ECM and soluble factors. To overcome these challenges we develop disease cell models, applying advanced cell culture approaches (3D culture, co-culture, cell immobilization) and systems (perfusion, bioreactors) to human stem cells and other patient-derived cells. I will discuss recent data on two of the main research lines in the lab. One is focused on the development of 3D cell models for recapitulation of human brain microenvironment. We have shown that differentiation of human induced pluripotent stem cells (hiPSC) as neurospheroids, in perfusion stirred tank bioreactors, promotes the expression of cellular and extracellular features found in neural tissue. We are now applying the neurospheroid model to address molecular defects in cell-ECM interactions associated with Mucopolysaccharidosis type VII (MPS VII), a lysosomal storage disease caused by deficient β-glucuronidase (β-gluc) activity, which leads to accumulation of glycosaminoglycans (GAGs) in many tissues, including the brain. We are also working on 3D cell models for recapitulation of tumor – macrophage crosstalk in carcinomas. We have shown that in our 3D-3-cultures (co-cultures of tumor cell spheroids, fibroblasts and monocytes) features of immunosuppressive cancer microenvironments are recapitulated. There is accumulation of cytokines, ECM and metalloproteinases, with infiltration of macrophages in the tumor mass and trans-polarization into M2-like phenotypes. Challenging of the system with therapeutic compounds induced modulation of the M2-like phenotype. We are now applying the 3D-3 culture model to depict tumor-associated macrophage phenotypes associated with different subtypes of breast cancer. 

 

Short CV

Catarina Brito is the Head of the Advanced Cell Models Laboratory of the Animal Cell Technology Unit of iBET and ITQB‐NOVA, since 2014. She holds a Biochemistry degree from the University of Lisbon and obtained her PhD in Biochemistry and Cell Biology with the New University of Lisbon. She pursued her PhD studies in the Laboratory of Glycobiology, at ITQB‐NOVA (Oeiras, Portugal) and Institut Jacques Monod (Paris, France) in the areas of glycobiology and intracellular trafficking. During her PhD, C. Brito contributed to the elucidation of the role of specific protein carbohydrate moieties in human neuronal differentiation and neuronal trafficking and explored glycosyltransferases for synthetic applications. She joined iBET (Portugal) in 2007, first as a postdoc working in human Stem Cell bioprocessing, focusing on human pluripotent stem cell expansion and neural differentiation, and later as a Senior Project Manager of academic and industrial collaborations, bridging her cell biology and cellular biotechnology expertise to develop preclinical cell models and bioassays.
 
Current Research is mostly translational and focused on development of advanced human cell models (employing induced pluripotent stem cells and other patient‐derived cells) to study deregulation of cellular microenvironment in disease progression and therapeutic response. The main research targets are Central Nervous System diseases and Cancer (solid tumours); C. Brito is engaged in collaborations in projects on neural and hepatic toxicology and stem cell‐based therapeutic approaches. Complementary to the research activities, C. Brito has been providing contract research services to the pharmaceutical & biotechnology industry in the areas of drug development and pre‐clinical research. 
 
CV Highlights: (i) 56 published papers; 5 book chapters; 1 patent submitted; h‐index: 19 (ii) supervision of 10 PhD students (4 defended), 7 post‐docs and 11 Master theses (9 defended); (iii) Chair, Scientific Board of the Analytical Services Unit, iBET; (iv) Member of the Executive Committee and Coordinator of the Biopharmaceutical Technology Profile of MolBioS‐PhD program in Molecular Biosciences; (v) Expert reviewer for several granting organizations (JPND‐EC, FWO‐Belgium, Research Councils‐UK, Breast Cancer Now‐UK, STW‐Netherlands, ANR; INSERM‐France); (vi) Referee of several international journals; (vii) visiting researcher at Harvard Medical School (September‐November 2013); (viii) Scientific Merit Prize New University of Lisbon‐2015. 
 
Email: anabrito@ibet.pt
Researcher ID link: A‐2389‐2009
Orcid: 0000‐0002‐8926‐279X
Scopus: 7007023897
 
Five selected publications
  • Simão D, Silva MM, Terrasso AP, Arez F, Sousa MFQ, Mehrjardi NZ, Šarić T, Gomes‐Alves P, Raimundo N, Alves PM, Brito C* “Human neural microenvironment specific features are promoted by 3D differentiation of iPSC‐derived NPC”, Stem Cell Reports, 11, 552‐564. 
    https://doi.org/10.1016/j.stemcr.2018.06.020
  • Terrasso AP, Bayó‐Puxan N, Creyssels S, Lory P, Cuervo AM, Simão D, Pescia C, Bernex F, Salinas S, Lavigne M, Vellard M, Levade T, Consiglio A, Brito C* & Kremer EJ (2018) “Lysosomal and network alterations in human mucopolysaccharidosis type VII iPSC‐derived neural cells”, Scientific Reports. https://doi.org/16644. 10.1038/s41598‐018‐34523‐3
  • Rebelo S, Pinto C, Martins TR, Harrer N, Estrada MF, Loza‐Alvarez P, Cabeçadas J, Alves PM, Gualda E, Sommergruber W, Brito C* (2018) “3D‐3‐culture: a tool to unveil macrophage plasticity in the tumour microenvironment”, Biomaterials, 163, 185‐197. 
    https://doi.org/10.1016/j.biomaterials.2018.02.030
  • Santo VE, Rebelo SP, Estrada MF, Alves PM, Boghaert E, Brito C* (2017) “Drug screening in 3D in vitro tumor models: overcoming current pitfalls of efficacy read‐outs”, Biotechnology Journal 12, 1600505.
    http://dx.doi.org/10.1002/biot.201600505
  • Estrada MF, Rebelo SP, Davies EJ, Pinto MT, Pereira H, Santo VE, Smalley MJ, Barry ST, Gualda EJ, Alves PM Anderson E, Brito C* (2016) Modelling the tumour microenvironment on long‐term microencapsulation 3D co‐cultures recapitulates phenotypic features of disease progression, Biomaterials 78, 50‐61.
    http://dx.doi.org/10.1016/j.biomaterials.2015.11.030